Onconova Therapeutics Quarterly Earnings. Should You Buy?


Onconova Therapeutics Quarterly Earnings. Should You Buy?: Onconova Therapeutics (NASDAQ: ONTX)  a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for patients with cancer, announces financial results for the twelve months ended December 31, 2020 and provides a business update. Highlights of the fourth quarter of 2020 and recent weeks include: ON 123300, Onconova’s proprietary multi-kinase inhibitor, received clearance from […]

Comments

Popular posts from this blog

Ulta Beauty CEO Mary Dillon, Steps Down

Trump’s Pardon Helps Paul Manafort To Keep $19 Million Properties, Cash & Fancy Jackets

Watch: 10 Killed in Mass Shooting in Monterey Park, California at Lunar New Year Celebration